Anti-CD30, Chimeric Antibody

Biosimilar to Brentuximab Vedotin, monoclonal antibody that targets CD30
Catalog #: A2177 | abID:

Product Details

Cat # +Size A2177-100
Size 100 μg
Antibody Target CD30
Alternate Name Ki-1, D1S166E, TNFRSF8
Host Human/Mouse chimeric
Antibody Type Monoclonal
Isotype IgG1, kappa
Immunogen Human CD30
Accession # DB08870
Gene ID 943
Appearance Colorless liquid
Formulation In PBS, pH 7.5
Purification Protein A purified
Species Reactivity Human
Handling The antibody solution should be gently mixed before use.
Storage Conditions -80°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

The research-grade biosimilar is a recombinant antibody that specifically targets CD30. CD30 is a member of the TNF-receptor superfamily and is expressed by activated, but not resting, T and B cells. CD30 is a positive regulator of apoptosis, and has been shown to limit the proliferation of autoreactive CD8 effector T cells in order to protect the body from autoimmunity.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.